ProShare Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-66,547
Closed -$6.7M 2001
2014
Q4
$6.7M Sell
66,547
-13,598
-17% -$1.06M 0.08% 268
2014
Q3
$5.32M Sell
80,145
-2,299
-3% -$151K 0.07% 274
2014
Q2
$5.76M Buy
82,444
+15,243
+23% +$1.04M 0.07% 262
2014
Q1
$4.92M Sell
67,201
-20,618
-23% -$1.54M 0.06% 295
2013
Q4
$6.05M Buy
87,819
+56,993
+185% +$3.69M 0.09% 234
2013
Q3
$1.96M Sell
30,826
-26,942
-47% -$1.63M 0.05% 412
2013
Q2
$2.79M Buy
+57,768
New +$2.84M 0.05% 333

ProShare Advisors's CBST Position: Q1 2015 in Review

ProShare Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 66,547 shares — an estimated $6.7M sold.

ProShare Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $6.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • ProShare Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • ProShare Advisors sold 66,547 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $6.7M.
  • ProShare Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • ProShare Advisors's CUBIST PHARMACEUTICALS INC position peaked at $6.7M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.